Health and Medicine
-
March 16, 2017
VUMC joins cutting-edge obesity research network
Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN). -
March 16, 2017
Premature infants in NICU do better with touch: study
Treatment in the Neonatal Intensive Care Unit (NICU) saves millions of infants born prematurely every year. But treatment is not without cost. Painful procedures such as needle pricks can impact early brain development. -
March 16, 2017
Esophageal cancer complexities
New findings that reveal complex interactions in esophageal adenocarcinoma could lead to diagnostic, prognostic or therapeutic biomarkers. -
March 9, 2017
Study explores alcohol use patterns in early pregnancy
The latest Centers for Disease Control and Prevention update recommending that women who are pregnant or could become pregnant abstain from alcohol use prompted a Vanderbilt professor of Obstetrics and Gynecology and her team to explore the patterns of alcohol use in early pregnancy. -
March 9, 2017
Certain risk factors linked to post-surgery infection
Plastic surgeons at Vanderbilt University Medical Center (VUMC) have published a prospective study that proves there are specific risk factors — such as obesity, smoking and diabetes — that contribute to development of a major surgical site infection following cosmetic surgery. -
March 9, 2017
Investigators use machine learning to predict suicide risk
According to the Centers for Disease Control and Prevention (CDC), in 2013 there were 41,149 suicides in the U.S., making it the 10th leading cause of death that year. Among high school students in 2013, the CDC estimates that over the previous 12 months 2.7 percent had sometime made a suicide attempt resulting in injury, poisoning or overdose that required medical attention. -
March 9, 2017
Melanoma study finds new way to enhance targeted therapies
With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.